Evidence map›Paper›PMID 32980598›Full record

ArticleNeuroImage. Clinical2020

Quantitative MRI outcomes in child and adolescent leukemia survivors: Evidence for global alterations in gray and white matter.

Ellen van der Plas, T Leigh Spencer Noakes, Darci T Butcher, Rosanna Weksberg, Laura Galin-Corini, Elizabeth A Wanstall, Patrick Te, Laura Hopf, Sharon Guger, Brenda J Spiegler and 4 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Cognitive performance and brain volume among survivors of pediatric hematological malignancies: a case-control study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Ellen van der PlasDepartment of Psychiatry, University of Iowa Hospital & Clinics, Iowa City, IA, USA.
T Leigh Spencer NoakesMouse Imaging Centre, Hospital for Sick Children, Toronto, ON, Canada; Translational Medicine, Hospital for Sick Children, Toronto, ON, Canada.
Darci T ButcherGenetics & Genome Biology, Hospital for Sick Children Research Institute, Toronto, ON, Canada; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
Rosanna WeksbergGenetics & Genome Biology, Hospital for Sick Children Research Institute, Toronto, ON, Canada; Clinical and Metabolic Genetics, Hospital for Sick Children Research Institute, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.
Laura Galin-CoriniTranslational Medicine, Hospital for Sick Children, Toronto, ON, Canada.
Elizabeth A WanstallDepartment of Psychology, The Hospital for Sick Children, Toronto, ON, Canada; Department of Psychology, York University, Toronto, ON, Canada.
Patrick TeTranslational Medicine, Hospital for Sick Children, Toronto, ON, Canada; Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, ON, Canada.
Laura HopfDepartment of Psychology, The Hospital for Sick Children, Toronto, ON, Canada.
Sharon GugerDepartment of Psychology, The Hospital for Sick Children, Toronto, ON, Canada.
Brenda J SpieglerDepartment of Psychology, The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Johann HitzlerDepartment of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; Developmental and Stem Cell Biology, Hospital for Sick Children, Toronto, ON, Canada; Division of Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada.
Russell J SchacharDepartment of Psychiatry, Hospital for Sick Children, Toronto, ON, Canada; Psychiatry Research, Hospital for Sick Children, Toronto, ON, Canada.
Shinya ItoTranslational Medicine, Hospital for Sick Children, Toronto, ON, Canada; Clinical Pharmacology and Toxicology, Hospital for Sick Children, Toronto, ON, Canada; Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Brian J NiemanMouse Imaging Centre, Hospital for Sick Children, Toronto, ON, Canada; Translational Medicine, Hospital for Sick Children, Toronto, ON, Canada; Ontario Institute for Cancer Research, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. Electronic address: brian.nieman@sickkids.ca.
Hospital for Sick Children · CAUniversity of Toronto · CAMcMaster University · CAUniversity of Iowa Hospitals and Clinics · USYork University · CA

Funding

Data Coordinating Center (DCC) for a MRI Study of Normal Brain DevelopmentN01MH90002 · NIMH · 2007 to 2008
$1.4M
PEDIATRIC STUDY CENTERS (PSCS) FOR A MRI STUDY OF NORMAL-265992315N01NS92315 · NINDS · UNIVERSITY OF CALIFORNIA LOS A · PI MCCRAKEN, JAMES · 2007 to 2007
$186k
PEDIATRIC STUDY CENTERS (PSCS) FOR A MRI STUDY OF NORMAL-265992319N01NS092319 · NINDS · WASHINGTON UNIVERSITY · 1999 to 2003
$106k
PEDIATRIC STUDY CENTERS (PSCS) FOR A MRI STUDY OF NORMAL-265992314N01NS092314 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · 1985 to 2003
$89k
PEDIATRIC STUDY CENTERS (PSCS) FOR A MRI STUDY OF NORMAL-265992315N01NS092315 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · 1999 to 2003
$77k
RESEARCH ROSTER FOR HUNTINGTON'S DISEASEN01NS092320 · NINDS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · 1985 to 2003
$59k
PEDIATRIC STUDY CENTERS (PSCS)FOR A MRI STUDY OF NORMAL-265992316N01NS092316 · NINDS · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · 1999 to 2003
$52k
PEDIATRIC STUDY CENTERS (PSCS) FOR A MRI STUDY OF NORMAL-265992317N01NS092317 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · 1999 to 2003
$48k
MRI STUDY OF NORMAL BRAIN DEVELOPMENT CLINICAL COORDINATING CENTER-275023343N01HD023343 · NICHD · WASHINGTON UNIVERSITY · PI BOTTERON, KELLY · 2006 to 2006
–
DATA COORDINATING CENTER (DCC) FOR A MRI STUDY OF NORMAL-278990002N01MH090002 · NIMH · NEUROVISION SCIENCES, INC. · 1999 to 2003
–
CIHR 142926NICHD NIH HHS N01 HD023343NIMH NIH HHS N01MH90002NINDS NIH HHS N01NS92314NINDS NIH HHS N01NS92315NINDS NIH HHS N01NS92316NINDS NIH HHS N01NS92317NINDS NIH HHS N01NS92319NINDS NIH HHS N01NS92320
6 · The paper itself

Abstract

introductionCure rates for pediatric acute lymphoblastic leukemia (ALL) have reached an all-time high (>90%); however, neurocognitive difficulties continue to affect quality of life in at least a subset of survivors. There are relatively few quantitative neuroimaging studies in child and adolescent ALL survivors treated with chemotherapy only. Use of different outcome measures or limited sample sizes restrict our ability to make inferences about patterns of brain development following chemotherapy treatment. In this study, we used magnetic resonance imaging (MRI) to evaluate brain outcomes in ALL survivors, comparing against a group of typically developing, cancer free peers. MATERIALS AND

methodsParticipants included 71 ALL survivors, on average 8 years after diagnosis and 8-18 years of age, and 83 typically developing controls. Anatomical MRI was performed to evaluate brain structure; diffusion and magnetization transfer MRI were used to examine brain tissue microstructure.

resultsSuccessful MRI scans were acquired in 67 survivors (94%) and 82 controls (99%). Structurally, ALL survivors exhibited widespread reductions in brain volume, with 6% less white matter and 5% less gray matter than controls (p = 0.003 and 0.0006 respectively). Much of the brain appeared affected - 71 of 90 evaluated structures showed smaller volume - with the most notable exception being the occipital lobe, where no significant differences were observed. Average full-scale IQ in the survivor and control groups were 95 (CI 92-99) and 110 (CI 107-113), respectively. Using data from the NIH Pediatric MRI Data Repository, we evaluated the extent to which elevated IQ in the control group might affect the structural differences observed. We estimated that two thirds of the observed brain differences were attributable to ALL and its treatment. In addition to the structural changes, survivors showed, on average, globally lower white matter fractional anisotropy (-3%) and higher radial diffusivity (+5%) (p < 10

conclusionsNeuroanatomical alterations in late childhood and adolescent ALL survivors treated with chemotherapy-only protocols are widespread, with white matter being somewhat more affected than gray matter. These MRI results indicate brain development is altered in ALL survivors and highlight the need to examine how these alterations emerge.

Indexed as

White MatterAdolescentAged, 80 and overBrainChildGray MatterHumansMagnetic Resonance ImagingQuality of LifeSurvivorsAcute lymphoblastic leukemiaChemotherapyGray matterLate effectsMagnetic resonance imagingWhite matter

Identifiers

PMID32980598
PMCPMC7522853
OpenAlexW3087713769

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.